NIH Reporter #5R01CA285866-02

Award for Research Services on Genetic Susceptibility to Aggressive Prostate Cancer

This opportunity involves a contract award by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), for specialized research services on genetic susceptibility to aggressive prostate cancer in men of African and European ancestry. - Government Buyer: - National Cancer Institute (NCI), NIH - Located in Los Angeles, CA - Scope of Work: - Research services focused on germline copy number variations and their role in aggressive prostate cancer - Includes data analysis, genetic sequencing, and imputation services - Vendors Mentioned: - Genomic Research Inc. - BioData Solutions - Requirements: - Compliance with NIH research guidelines - Pre-bid meeting was strongly recommended - Estimated Contract Value: - $580,221 - No specific part numbers or product quantities listed, as this is a service-based procurement - Notable for its focus on health disparities and advanced genetic research methodologies

Description

This solicitation is for research services related to the contribution of germline copy number variations to the susceptibility of aggressive prostate cancer in men of African and European ancestry. The scope includes data analysis, sequencing, and imputation services. The project is awarded and active under the National Cancer Institute (NCI), part of the NIH. Bidders must comply with NIH guidelines and are encouraged to attend a pre-bid meeting.

View original listing